Delivery Order SPE2DB22D3010-SPE2DB25FP3NB
Award Date 9/17/25
Potential Completion Date 9/18/25
Potential Value $1.5K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for RHOFADE 1% Cream 30GM under a firm fixed-price contract. The award, issued on July 30, 2025, carries a ceiling value of $2,424.79 and is scheduled for ultimate completion by July 31, 2025. This non-competitive delivery order represents a small-value pharmaceutical procurement executed from the company's existing contract vehicle to support federal medical supply requirements. This delivery order is...
- The U.S. Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of RHOFADE 1% Cream in 30-gram quantities. This is a firm fixed-price delivery order with a ceiling value of $1,143.78 and an ultimate completion date of August 6, 2025. The contract was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for RHOFADE 1% Cream in a 30-gram quantity, with a ceiling value of $1,525.04 and firm fixed pricing. This non-set-aside competitive award was issued as a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The...
- This is a federal delivery order award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the delivery of RHOFADE 1% cream, a pharmaceutical product, with a ceiling value of $1,331.05 and a period of performance ending on October 11, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which enables the DLA Troop Support Medical to efficiently...
- This firm fixed price delivery order worth $1,956.79 was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The order is for the supply of RHOFADE 1% cream, a 30 gram product, with a completion date of March 6, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of RHOFADE 1% cream in 30 gram units. The $2,445.82 order has a completion date of January 4, 2024. This order is part of Amerisourcebergen Drug Corp's existing indefinite delivery contract with DLA to provide pharmaceuticals and medical supplies in support of military treatment programs and facilities. No set aside designation...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of RHOFADE 1% cream, a topical medication, with a ceiling value of $1,355.38 and a completion date of June 17, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
- This federal contract award, with a value of $2,212.18, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RHOFADE 1% cream, a topical medication, and has a completion date of February 25, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a competitive delivery order valued at $1,329.35 on September 15, 2025, for the supply of Rhofade 1% Cream in a 30-gram quantity. The contract carries a firm fixed price structure with an ultimate completion date of September 16, 2025, and was funded through the Defense Logistics Agency's Medical Supply Chain, which supports pharmaceutical procurement for military and...
- This federal contract award, valued at $2,533.43, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of RHOFADE 1% CREAM 30GM, a pharmaceutical product, and has an ultimate completion date of February 6, 2024. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and...